{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:21:07Z","timestamp":1764249667099,"version":"3.46.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00059-025-05338-6","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:48:00Z","timestamp":1757580480000},"page":"446-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Der erste ICD(implantierbarer Kardioverter-Defibrillator)-Schock","First cardioverter defibrillator (ICD) shock"],"prefix":"10.1007","volume":"50","author":[{"given":"Thomas","family":"Kleemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"10","key":"5338_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole\u00a0JE, Johnson\u00a0GW, Hellkamp\u00a0AS et\u00a0al (2008) Prognostic importance of defibrillator shocks in patients with heart failure. N\u00a0Engl J Med 359(10):1009\u20131017. https:\/\/doi.org\/10.1056\/NEJMoa071098","journal-title":"N Engl J Med"},{"issue":"10","key":"5338_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa0706719","volume":"359","author":"DB Mark","year":"2008","unstructured":"Mark\u00a0DB, Anstrom\u00a0KJ, Sun\u00a0JL et\u00a0al (2008) Quality of life with defibrillator therapy or amiodarone in heart failure. N\u00a0Engl J Med 359(10):999\u20131008. https:\/\/doi.org\/10.1056\/NEJMoa0706719","journal-title":"N Engl J Med"},{"issue":"1","key":"5338_CR3","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10840-024-01873-0","volume":"68","author":"DM Frodi","year":"2025","unstructured":"Frodi\u00a0DM, Diederichsen\u00a0SZ, Xing\u00a0LY et\u00a0al (2025) Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillator. J\u00a0Interv Card Electrophysiol 68(1):125\u2013139. https:\/\/doi.org\/10.1007\/s10840-024-01873-0","journal-title":"J Interv Card Electrophysiol"},{"issue":"5","key":"5338_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/jce.15906","volume":"34","author":"E Lampropoulou","year":"2023","unstructured":"Lampropoulou\u00a0E, Kouraki\u00a0K, Strauss\u00a0M et\u00a0al (2023) The role of trigger factors in the occurrence of appropriate ICD shocks and their clinical and prognostic implications. J\u00a0Cardiovasc Electrophysiol 34(5):1241\u20131248. https:\/\/doi.org\/10.1111\/jce.15906","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"40","key":"5338_CR5","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld\u00a0K, Tfelt-Hansen\u00a0J, de Riva\u00a0M et\u00a0al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart\u00a0J 43(40):3997\u20134126. https:\/\/doi.org\/10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"issue":"9","key":"5338_CR6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/europace\/euz065","volume":"21","author":"MK Stiles","year":"2019","unstructured":"Stiles\u00a0MK, Fauchier\u00a0L, Morillo\u00a0CA et\u00a0al (2019) 2019 HRS\/EHRA\/APHRS\/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. Europace 21(9):1442\u20131443. https:\/\/doi.org\/10.1093\/europace\/euz065","journal-title":"Europace"},{"issue":"5","key":"5338_CR7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.hroo.2021.08.005","volume":"2","author":"T Kleemann","year":"2021","unstructured":"Kleemann\u00a0T, Lampropoulou\u00a0E, Kouraki\u00a0K et\u00a0al (2021) Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: a\u00a03-step treatment concept. Heart Rhythm O2 2(5):537\u2013540. https:\/\/doi.org\/10.1016\/j.hroo.2021.08.005","journal-title":"Heart Rhythm O2"},{"issue":"12","key":"5338_CR8","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/europace\/euaa232","volume":"22","author":"GN Kowlgi","year":"2020","unstructured":"Kowlgi\u00a0GN, Cha\u00a0YM (2020) Management of ventricular electrical storm: a\u00a0contemporary appraisal. Europace 22(12):1768\u20131780. https:\/\/doi.org\/10.1093\/europace\/euaa232","journal-title":"Europace"},{"issue":"24","key":"5338_CR9","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","volume":"367","author":"AJ Moss","year":"2012","unstructured":"Moss\u00a0AJ, Schuger\u00a0C, Beck\u00a0CA et\u00a0al (2012) Reduction in inappropriate therapy and mortality through ICD programming. N\u00a0Engl J Med 367(24):2275\u20132283. https:\/\/doi.org\/10.1056\/NEJMoa1211107","journal-title":"N Engl J Med"},{"issue":"11","key":"5338_CR10","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/europace\/euw032","volume":"18","author":"A Arenal","year":"2016","unstructured":"Arenal\u00a0A, Proclemer\u00a0A, Kloppe\u00a0A et\u00a0al (2016) Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial. Europace 18(11):1719\u20131725. https:\/\/doi.org\/10.1093\/europace\/euw032","journal-title":"Europace"},{"issue":"2","key":"5338_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.295.2.165","volume":"295","author":"SJ Connolly","year":"2006","unstructured":"Connolly\u00a0SJ, Dorian\u00a0P, Roberts\u00a0RS et\u00a0al (2006) Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Investigators. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a\u00a0randomized trial. JAMA 295(2):165\u2013171. https:\/\/doi.org\/10.1001\/jama.295.2.165","journal-title":"JAMA"},{"issue":"1","key":"5338_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1540-8167.2009.01563.x","volume":"21","author":"H Tanner","year":"2010","unstructured":"Tanner\u00a0H, Hindricks\u00a0G, Volkmer\u00a0M et\u00a0al (2010) Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J\u00a0Cardiovasc Electrophysiol 21(1):47\u201353. https:\/\/doi.org\/10.1111\/j.1540-8167.2009.01563.x","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"8","key":"5338_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1056\/NEJMoa2409501","volume":"392","author":"JL Sapp","year":"2025","unstructured":"Sapp\u00a0JL, Tang\u00a0ASL, Parkash\u00a0R et\u00a0al (2025) Catheter ablation or antiarrhythmic drugs for ventricular tachycardia. N\u00a0Engl J Med 392(8):737\u2013747. https:\/\/doi.org\/10.1056\/NEJMoa2409501","journal-title":"N Engl J Med"},{"issue":"2","key":"5338_CR14","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1513614","volume":"375","author":"JL Sapp","year":"2016","unstructured":"Sapp\u00a0JL, Wells\u00a0GA, Parkash\u00a0R et\u00a0al (2016) Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N\u00a0Engl J Med 375(2):111\u2013121. https:\/\/doi.org\/10.1056\/NEJMoa1513614","journal-title":"N Engl J Med"},{"issue":"13","key":"5338_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","volume":"141","author":"S Willems","year":"2020","unstructured":"Willems\u00a0S, Tilz\u00a0RR, Steven\u00a0D et\u00a0al (2020) Preventive or deferred ablation of ventricular tachycardia in patients with Ischemic cardiomyopathy and Implantable Defibrillator (BERLIN VT): a\u00a0multicenter randomized trial. Circulation 141(13):1057\u20131067. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.043400","journal-title":"Circulation"},{"issue":"25","key":"5338_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","volume":"145","author":"DP Bella","year":"2022","unstructured":"Bella\u00a0DP, Baratto\u00a0F, Vergara\u00a0P et\u00a0al (2022) Does timing of ventricular tachycardia ablation affect prognosis in patients with an Implantable cardioverter defibrillator? Results from the multicenter randomized PARTITA trial. Circulation 145(25):1829\u20131838. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059598","journal-title":"Circulation"},{"issue":"9708","key":"5338_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","volume":"375","author":"KH Kuck","year":"2010","unstructured":"Kuck\u00a0KH, Schaumann\u00a0A, Eckardt\u00a0L et\u00a0al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a\u00a0multicentre randomised controlled trial. Lancet 375(9708):31\u201340. https:\/\/doi.org\/10.1016\/S0140-6736(09)61755-4","journal-title":"Lancet"},{"issue":"26","key":"5338_CR18","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1056\/NEJMoa065457","volume":"357","author":"VY Reddy","year":"2007","unstructured":"Reddy\u00a0VY, Reynolds\u00a0MR, Neuzil\u00a0P et\u00a0al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N\u00a0Engl J Med 357(26):2657\u20132665. https:\/\/doi.org\/10.1056\/NEJMoa065457","journal-title":"N Engl J Med"},{"issue":"11","key":"5338_CR19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ejhf.887","volume":"19","author":"M Komajda","year":"2017","unstructured":"Komajda\u00a0M, Cowie\u00a0MR, Tavazzi\u00a0L et\u00a0al (2017) Physicians\u2019 guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. Eur J Heart Fail 19(11):1414\u20131423. https:\/\/doi.org\/10.1002\/ejhf.887","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"5338_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","volume":"15","author":"C de Diego","year":"2018","unstructured":"de Diego\u00a0C, Gonz\u00e1lez-Torres\u00a0L, N\u00fa\u00f1ez\u00a0JM et\u00a0al (2018) Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices. Heart Rhythm 15(3):395\u2013402. https:\/\/doi.org\/10.1016\/j.hrthm.2017.11.012","journal-title":"Heart Rhythm"},{"issue":"21","key":"5338_CR21","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray\u00a0JJV, Solomon\u00a0SD, Inzucchi\u00a0SE et\u00a0al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N\u00a0Engl J Med 381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","journal-title":"N Engl J Med"},{"issue":"15","key":"5338_CR22","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer\u00a0M, Anker\u00a0SD, Butler\u00a0J et\u00a0al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N\u00a0Engl J Med 383(15):1413\u20131424. https:\/\/doi.org\/10.1056\/NEJMoa2022190","journal-title":"N Engl J Med"},{"issue":"15","key":"5338_CR23","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMoa050496","volume":"352","author":"JG Cleland","year":"2005","unstructured":"Cleland\u00a0JG, Daubert\u00a0JC, Erdmann\u00a0E et\u00a0al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N\u00a0Engl J Med 352(15):1539\u20131549. https:\/\/doi.org\/10.1056\/NEJMoa050496","journal-title":"N Engl J Med"},{"issue":"9","key":"5338_CR24","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1093\/europace\/euz061","volume":"21","author":"J Ledwoch","year":"2019","unstructured":"Ledwoch\u00a0J, Nommensen\u00a0A, Keelani\u00a0A et\u00a0al (2019) Impact of transcatheter mitral valve repair on ventricular arrhythmias. Europace 21(9):1385\u20131391. https:\/\/doi.org\/10.1093\/europace\/euz061","journal-title":"Europace"},{"issue":"23","key":"5338_CR25","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","volume":"364","author":"CR Smith","year":"2011","unstructured":"Smith\u00a0CR, Leon\u00a0MB, Mack\u00a0MJ et\u00a0al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N\u00a0Engl J Med 364(23):2187\u20132198. https:\/\/doi.org\/10.1056\/NEJMoa1103510","journal-title":"N Engl J Med"},{"issue":"5","key":"5338_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMoa1707855","volume":"378","author":"NF Marrouche","year":"2018","unstructured":"Marrouche\u00a0NF, Brachmann\u00a0J, Andresen\u00a0D et\u00a0al (2018) Catheter Ablation for Atrial Fibrillation with Heart Failure. N\u00a0Engl J Med 378(5):417\u2013427. https:\/\/doi.org\/10.1056\/NEJMoa1707855","journal-title":"N Engl J Med"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05338-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:19:16Z","timestamp":1764249556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05338-6"}},"subtitle":["Diagnostisches und therapeutisches Vorgehen","Diagnostic and therapeutic procedure"],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5338"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05338-6","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"26 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"T.\u00a0Kleemann und R.\u00a0Zahn geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}